BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Chineham
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708


SEARCH JOBS




Industry
Pharmaceutical






 Company News
New Shire (SHPGY) Research To Be Presented At World Congress On ADHD Highlights Treatment Portfolio, Pipeline And Caregiver Experiences 5/26/2015 9:26:01 AM
New Shire (SHPGY) Research To Be Presented At World Congress On ADHD Highlights Treatment Portfolio, Pipeline And Caregiver Experiences 5/26/2015 8:02:05 AM
LCS Group Announces Exclusive License From Lucerne Biosciences To Commercialize '813 Patent And '249 Application Through Shire (SHPGY)'s Marketing Of Lisdexamfetamine Dimesylate For Binge Eating Disorder 5/14/2015 6:33:29 AM
Shire (SHPGY) To Present New Research At American Psychiatric Association Annual Meeting 5/11/2015 12:36:05 PM
Shire (SHPGY) To Participate At The Deutsche Bank (DB) 40th Annual Healthcare Conference 5/7/2015 12:03:20 PM
Shire (SHPGY) And Foundation Fighting Blindness Announce New Research Agreement 5/4/2015 11:12:14 AM
Shire (SHPGY) Delivers Strong Revenue Growth And Cash Generation; 20% Increase In Non GAAP Earnings Per ADS 5/1/2015 9:06:17 AM
Jeff Poulton Appointed Shire (SHPGY) Chief Financial Officer And Joins Board Of Directors 4/30/2015 6:28:54 AM
Shire (SHPGY) Release: FDA Grants Priority Review To Lifitegrast NDA For The Treatment Of Dry Eye Disease In Adults 4/10/2015 10:40:41 AM
Shire (SHPGY) Reports Topline Results From First Of Three Placebo-Controlled Phase 2 Studies Of SHP625 (LUM001) In Children With Alagille Syndrome 4/9/2015 6:52:26 AM
12345678910...